Brawn Biotech Profile
Key Indicators
- Authorised Capital ₹ 4.50 Cr
as on 02-12-2024
- Paid Up Capital ₹ 3.00 Cr
as on 02-12-2024
- Company Age 39 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 3.03 M
as on 02-12-2024
- Revenue -75.56%
(FY 2022)
- Profit -198.65%
(FY 2022)
- Ebitda -235.00%
(FY 2022)
- Net Worth -17.90%
(FY 2022)
- Total Assets -0.64%
(FY 2022)
About Brawn Biotech
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 530207.
The Corporate was formerly known as Brawn Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.50 Cr and a paid-up capital of Rs 3.00 Cr.
The company has closed loans amounting to ₹3.03 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Brawn Biotech Limited India are Pooja Pandey as CFO and Priyanka Sharma as Company Secretary. Brij Gupta, Brij Gupta, Subhash Chander, and One other member serve as directors at the Company.
- CIN/LLPIN
L74899DL1985PLC022468
- Company No.
022468
- Stock Symbol
BSE : 530207
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
07 Nov 1985
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Brawn Biotech Limited offer?
Brawn Biotech Limited offers a wide range of products and services, including Chemical Reagents & Catalysts, Laboratory Reagents.
Who are the key members and board of directors at Brawn Biotech?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pooja Pandey | CFO | 05-Aug-2022 | Current |
Priyanka Sharma  | Company Secretary | 01-Jan-2019 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Brij Gupta | Director | 07-Nov-1985 | Current |
| Brij Gupta | Director | 24-Nov-2004 | Current |
| Subhash Chander | Director | 10-Nov-2017 | Current |
| Kanta Takkar | Director | 10-Nov-2017 | Current |
Financial Performance of Brawn Biotech.
Brawn Biotech Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 75.56% decrease. The company also saw a substantial fall in profitability, with a 198.65% decrease in profit. The company's net worth observed a substantial decline by a decrease of 17.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Brawn Biotech?
In 2022, Brawn Biotech had a promoter holding of 53.71% and a public holding of 46.29%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Punjab National Bank Creation Date: 21 Apr 2015 | ₹0.67 M | Satisfied |
Punjab National Bank Creation Date: 21 Apr 2015 | ₹0.67 M | Satisfied |
Punjab National Bank Creation Date: 09 Apr 2014 | ₹1.46 M | Satisfied |
How Many Employees Work at Brawn Biotech?
Unlock and access historical data on people associated with Brawn Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Brawn Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Brawn Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
